Mitral Regurgitation
Mitral Regurgitation is a topic covered in the Washington Manual of Medical Therapeutics.
To view the entire topic, please log in or purchase a subscription.
The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
- Prevention of MR is dependent on the integrated and proper function of the MV (annulus and leaflets), subvalvular apparatus (chordae tendineae and papillary muscles), LA, and LV; abnormal function or size of any one of these components can lead to MR.
- Primary MR refers to MR caused primarily by lesions to the valve leaflets and/or chordae tendineae (i.e., myxomatous degeneration, endocarditis, rheumatic).
- Secondary MR, or functional MR, refers to MR caused primarily by ventricular dysfunction usually with accompanying annular dilatation (i.e., dilated cardiomyopathy and ischemic MR).
- It is critical to define the mechanism of MR and the time course (acute vs. chronic) because these significantly impact clinical management.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
- Prevention of MR is dependent on the integrated and proper function of the MV (annulus and leaflets), subvalvular apparatus (chordae tendineae and papillary muscles), LA, and LV; abnormal function or size of any one of these components can lead to MR.
- Primary MR refers to MR caused primarily by lesions to the valve leaflets and/or chordae tendineae (i.e., myxomatous degeneration, endocarditis, rheumatic).
- Secondary MR, or functional MR, refers to MR caused primarily by ventricular dysfunction usually with accompanying annular dilatation (i.e., dilated cardiomyopathy and ischemic MR).
- It is critical to define the mechanism of MR and the time course (acute vs. chronic) because these significantly impact clinical management.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Mitral Regurgitation." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. Washington Manual Redesign, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602124/all/Mitral_Regurgitation.
Mitral Regurgitation. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602124/all/Mitral_Regurgitation. Accessed January 27, 2023.
Mitral Regurgitation. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602124/all/Mitral_Regurgitation
Mitral Regurgitation [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 January 27]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602124/all/Mitral_Regurgitation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mitral Regurgitation
ID - 602124
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602124/all/Mitral_Regurgitation
PB - Wolters Kluwer Health
ET - 35
DB - Washington Manual Redesign
DP - Unbound Medicine
ER -